1.89
-5.03%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Meridian Bioscience
Its shares trade under the ticker VIVO. It has been listed since 29 July 1986. In the fiscal year to 30 September 2022, it reported revenue of $333.0m and net income of $42.5m. At that date it held total assets of $463.1m and shareholders' equity of $368.1m.
Meridian Bioscience, Inc. engages in the development, manufacture, sale, and distribution of diagnostic test kits, antigens, reagents, and related products. The company is headquartered in Cincinnati, Ohio. Its segments include Diagnostics and Life Science. The Diagnostics segment includes manufacturing operations in Cincinnati, and the sale and distribution of diagnostic test kits in the countries consisting of North, Central and South America; Europe, the Middle East and Africa (EMEA), and other countries outside of the Americas and EMEA. The Life Science segment consists of manufacturing operations in Memphis, Tennessee; Boca Raton, Florida; London, England; Luckenwalde, Germany, and Sydney, Australia.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Listed since
- 29 Jul 1986
- Employees
- 660
- Website
- meridianbioscience.com ↗
- Head office
- SUITE 4, 7TH FLOOR 50 BROADWAY, LONDON, SW1H 0DB
- Incorporated in
- X0
- Classification
- Electric & Other Services Combined
- Filer status
- Non-accelerated filer
Leadership
Pay as last reported
- Mr. John KennyChief Executive Officer, Director, since 2017$4.6m
- Mr. Andrew KitzmillerChief Financial Officer, Executive Vice President, Director, since 2022$882,896
- Mr. Tony Serafini - LamannaExecutive Vice President - Diagnostics$1.2m
- Dr. Lourdes WeltzienExecutive Vice President - Life Science$1.2m
- Ms. Julie SmithSenior Vice President, Principal Accounting Officer, Controller$786,416
- Mr. Charlie WoodVice President - Investor Relations, since 2021
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Meridian Bioscience Inc has a strong reputation in the healthcare industry, particularly in the field of diagnostics and testing kits. The company's advanced technology and extensive product portfolio give it a competitive edge.
- Meridian Bioscience Inc has a solid financial position with stable revenues and profits. Its strong financial standing allows the company to invest in research and development, innovate its product offerings, and expand its market presence.
Weaknesses
- Despite its strong reputation and financial position, Meridian Bioscience Inc faces certain weaknesses. The company relies heavily on a few key customers for a significant portion of its revenue, which creates a dependency and increases the risk of revenue fluctuations.
- Another weakness is the limited geographical presence of Meridian Bioscience Inc. The company primarily operates within the United States, which restricts its market reach and exposes it to potential risks associated with regional economic downturns or regulatory changes.
Opportunities
- The increasing global demand for diagnostics and healthcare products presents significant opportunities for Meridian Bioscience Inc. The company can expand its market presence by entering new geographical regions and tapping into emerging markets with a growing need for healthcare solutions.
- Furthermore, advancements in technology and the ongoing COVID-19 pandemic have accelerated the importance of rapid testing and diagnostics. Meridian Bioscience Inc can leverage these opportunities to develop and market innovative solutions that address the evolving healthcare landscape.
Threats
- Meridian Bioscience Inc faces competition from other established players in the healthcare industry. The presence of larger competitors with greater resources and market presence poses a threat to the company's market share and growth prospects.
- Additionally, regulatory challenges and changing government policies can create uncertainties for Meridian Bioscience Inc. Compliance with evolving regulations and adherence to quality standards require continuous monitoring and can impact the company's operations and profitability.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.